Short-term mortality prediction in acute pulmonary embolism: Radiomics values of skeletal muscle and intramuscular adipose tissue.
acute pulmonary embolism
computer tomographic pulmonary angiography
intramuscular adipose tissue
machine learning
radiomics
skeletal musculature
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
10 Jun 2024
10 Jun 2024
Historique:
revised:
08
03
2024
received:
03
11
2023
accepted:
22
03
2024
medline:
11
6
2024
pubmed:
11
6
2024
entrez:
11
6
2024
Statut:
aheadofprint
Résumé
Acute pulmonary embolism (APE) is a potentially life-threatening disorder, emphasizing the importance of accurate risk stratification and survival prognosis. The exploration of imaging biomarkers that can reflect patient survival holds the potential to further enhance the stratification of APE patients, enabling personalized treatment and early intervention. Therefore, in this study, we develop computed tomography pulmonary angiography (CTPA) radiomic signatures for the prognosis of 7- and 30-day all-cause mortality in patients with APE. Diagnostic CTPA images from 829 patients with APE were collected. Two hundred thirty-four features from each skeletal muscle (SM), intramuscular adipose tissue (IMAT) and both tissues combined (SM + IMAT) were calculated at the level of thoracic vertebra 12. Radiomic signatures were derived using 10 times repeated three-fold cross-validation on the training data for SM, IMAT and SM + IMAT for predicting 7- and 30-day mortality independently. The performance of the radiomic signatures was then evaluated on held-out test data and compared with the simplified pulmonary embolism severity index (sPESI) score, a well-established biomarker for risk stratification in APE. Predictive accuracy was assessed by the area under the receiver operating characteristic curve (AUC) with a 95% confidence interval (CI), sensitivity and specificity. The radiomic signatures based on IMAT and a combination of SM and IMAT (SM + IMAT) achieved moderate performance for the prediction of 30-day mortality on test data (IMAT: AUC = 0.68, 95% CI [0.57-0.78], sensitivity = 0.57, specificity = 0.73; SM + IMAT: AUC = 0.70, 95% CI [0.60-0.79], sensitivity = 0.74, specificity = 0.54). Radiomic signatures developed for predicting 7-day all-cause mortality showed overall low performance. The clinical signature, that is, sPESI, achieved slightly better performance in terms of AUC on test data compared with the radiomic signatures for the prediction of both 7- and 30-day mortality on the test data (7 days: AUC = 0.73, 95% CI [0.67-0.79], sensitivity = 0.92, specificity = 0.16; 30 days: AUC = 0.74, 95% CI [0.66-0.82], sensitivity = 0.97, specificity = 0.16). We developed and tested radiomic signatures for predicting 7- and 30-day all-cause mortality in APE using a multicentric retrospective dataset. The present multicentre work shows that radiomics parameters extracted from SM and IMAT can predict 30-day all-cause mortality in patients with APE.
Sections du résumé
BACKGROUND
BACKGROUND
Acute pulmonary embolism (APE) is a potentially life-threatening disorder, emphasizing the importance of accurate risk stratification and survival prognosis. The exploration of imaging biomarkers that can reflect patient survival holds the potential to further enhance the stratification of APE patients, enabling personalized treatment and early intervention. Therefore, in this study, we develop computed tomography pulmonary angiography (CTPA) radiomic signatures for the prognosis of 7- and 30-day all-cause mortality in patients with APE.
METHODS
METHODS
Diagnostic CTPA images from 829 patients with APE were collected. Two hundred thirty-four features from each skeletal muscle (SM), intramuscular adipose tissue (IMAT) and both tissues combined (SM + IMAT) were calculated at the level of thoracic vertebra 12. Radiomic signatures were derived using 10 times repeated three-fold cross-validation on the training data for SM, IMAT and SM + IMAT for predicting 7- and 30-day mortality independently. The performance of the radiomic signatures was then evaluated on held-out test data and compared with the simplified pulmonary embolism severity index (sPESI) score, a well-established biomarker for risk stratification in APE. Predictive accuracy was assessed by the area under the receiver operating characteristic curve (AUC) with a 95% confidence interval (CI), sensitivity and specificity.
RESULTS
RESULTS
The radiomic signatures based on IMAT and a combination of SM and IMAT (SM + IMAT) achieved moderate performance for the prediction of 30-day mortality on test data (IMAT: AUC = 0.68, 95% CI [0.57-0.78], sensitivity = 0.57, specificity = 0.73; SM + IMAT: AUC = 0.70, 95% CI [0.60-0.79], sensitivity = 0.74, specificity = 0.54). Radiomic signatures developed for predicting 7-day all-cause mortality showed overall low performance. The clinical signature, that is, sPESI, achieved slightly better performance in terms of AUC on test data compared with the radiomic signatures for the prediction of both 7- and 30-day mortality on the test data (7 days: AUC = 0.73, 95% CI [0.67-0.79], sensitivity = 0.92, specificity = 0.16; 30 days: AUC = 0.74, 95% CI [0.66-0.82], sensitivity = 0.97, specificity = 0.16).
CONCLUSIONS
CONCLUSIONS
We developed and tested radiomic signatures for predicting 7- and 30-day all-cause mortality in APE using a multicentric retrospective dataset. The present multicentre work shows that radiomics parameters extracted from SM and IMAT can predict 30-day all-cause mortality in patients with APE.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : 01KX2021
Informations de copyright
© 2024 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.
Références
Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386–1389.
Ng ACC, Chung T, Sze Chiang Yong A, et al. Long‐term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Cardiol Res Pract 2011;4:122–128.
Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041–1046.
Zondag W, Mos ICM, Creemers‐Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011;9:1500–1507.
Palas M, Silva BV, Jorge C, Almeida AG, Pinto FJ, Caldeira D. The accuracy of Hestia and simplified PESI to predict the prognosis in pulmonary embolism: systematic review with meta‐analysis. TH Open 2022;6:e347–e353.
Gupta R, Fortman DD, Morgenstern DR, Cooper CJ. Short‐ and long‐term mortality risk after acute pulmonary embolism. Clin Cardiol 2018;20:30311090.
Meinel FG, Nance JW Jr, Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, et al. Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta‐analysis. Am J Med 2015;128:747–759.
Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, Halil M. Sarcopenia in critically ill patients. J Anesth 2016;30:884–890.
Simpson G, Wilson J, Vimalachandran D, McNicol F, Magee C. Sarcopenia estimation using psoas major enhances P‐POSSUM mortality prediction in older patients undergoing emergency laparotomy: cross‐sectional study. Eur J Trauma Emerg Surg 2021;1–10.
Meyer HJ, Wienke A, Surov A. Computed tomography‐defined body composition as prognostic markers for unfavorable outcomes and in‐hospital mortality in coronavirus disease 2019. J Cachexia Sarcopenia Muscle 2022;13:159–168.
Meyer HJ, Benkert F, Bailis N, Lerche M, Denecke T, Surov A. Low skeletal muscle mass defined by thoracic CT as a prognostic marker in acute pulmonary embolism. Eur J Radiol 2022;98:111622.
Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, et al. The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics 2019;9:1303–1322.
Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics 2017;37:1483–1503.
Leonhardi J, Bailis N, Lerche M, Denecke T, Surov A, Meyer HJ. Computed tomography embolus texture analysis as a prognostic marker of acute pulmonary embolism. J Am Coll Radiol 2023;74:461–471.
Zwanenburg A, Leger S, Agolli L, Pilz K, Troost EGC, Richter C, et al. Assessing robustness of radiomic features by image perturbation. Sci Rep 2019;9:614.
Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high‐throughput image‐based phenotyping. Radiology 2020;295:328–338.
Zwanenburg A. Standardisation and harmonisation efforts in quantitative imaging. Eur Radiol 2023;33:8842–8843.
Zwanenburg A, Löck S. familiar: end‐to‐end automated machine learning and model evaluation. 2021. Available from: https://github.com/alexzwanenburg/familiar
Peng H, Long F, Ding C. Feature selection based on mutual information criteria of max‐dependency, max‐relevance, and min‐redundancy. IEEE Trans Pattern Anal Mach Intell 2005;27:1226–1238.
Gel'fand IM, Yaglom AM. Computation of the amount of information about a stochastic function contained in another such function. Am Math Soc Transl 1957;12:3–52.
Cox DR. The regression analysis of binary sequences. J R Stat Soc B Methodol 1958;20:215–232.
Chen T, Guestrin C. Xgboost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; 2016. p 785–794.
Breiman L. Bagging predictors. Mach Learn 1996;24:123–140.
Hothorn T, Lausen B. On the exact distribution of maximally selected rank statistics. Comput Stat Data Anal 2003;43:121–137.
Efron B, Hastie T. Computer age statistical inference. Cambridge University Press; 2016.
Hosmer DW, Lemesbow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat ‐ Theory Methods 1980;9:1043–1069.
Konstantinides SV, Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2019;40:3453–3455.
Zhou XY, Ben SQ, Chen HL, Ni SS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta‐analysis. Respir Res 2012;13:111.
Nithianandan H, Reilly A, Tritschler T, Wells PS. Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: a systematic review and meta‐analysis. Thromb Res 2020;195:195–208.
Söhne M, ten Wolde M, Boomsma F, et al. Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost 2006;4:552–556.
Lankeit M, Jiménez D, Kostrubiec M, et al. Validation of N‐terminal pro‐brain natriuretic peptide cut‐off values for risk stratification of pulmonary embolism. J Thromb Haemost 2014;43:1669–1677.
Wiliński J, Skwarek A, Borek R, Chukwu O, Ciuk K, Stolarz‐Skrzypek K, et al. Subcostal echocardiographic assessment of tricuspid annular kick (SEATAK): a novel independent predictor of 30‐day mortality in patients with acute pulmonary embolism. J Am Soc Echocardiogr 2022;80:1127–1135.
Foley RW, Glenn‐Cox S, Rossdale J, Mynott G, Burnett TA, Brown WJH, et al. Automated calculation of the right ventricle to left ventricle ratio on CT for the risk stratification of patients with acute pulmonary embolism. J Cardiovasc Comput Tomogr 2021;31:6013–6020.
Han DS, Chang KV, Li CM, Lin YH, Kao TW, Tsai KS, et al. Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia. Sci Rep 2016;6:19457.
Chang KV, Chen JD, Wu WT, Huang KC, Hsu CT, Han DS. Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta‐analysis. Liver Cancer 2018;7:90–103.
Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998;85:115–122.
Saalfeld S, Kreher R, Hille G, Niemann U, Hinnerichs M, Öcal O, et al. Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients. J Cachexia Sarcopenia Muscle 2023;14:2301–2309.
Addison O, Marcus RL, LaStayo PC, Ryan AS. Intermuscular fat: a review of the consequences and causes. Int J Endocrinol 2014.
Liao Q, Qu S, Tang LX, Li LP, He DF, Zeng CY, et al. Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis. Acta Pharmacol Sin 2019;40:1314–1321.
Harris MP, Zeng S, Zhu Z, Lira VA, Yu L, Hodgson‐Zingman DM, et al. Myokine musclin is critical for exercise‐induced cardiac conditioning. Int J Mol Sci 2023;24:6525.
Szaroszyk M, Kattih B, Martin‐Garrido A, Trogisch FA, Dittrich GM, Grund A, et al. Skeletal muscle derived Musclin protects the heart during pathological overload. Nat Commun 2022;13:149.
Otaka N, Shibata R, Ohashi K, Uemura Y, Kambara T, Enomoto T, et al. Myonectin is an exercise‐induced myokine that protects the heart from ischemia‐reperfusion injury. Circ Res 2018;123:1326–1338.
Szabó MR, Pipicz M, Csont T, Csonka C. Modulatory effect of myokines on reactive oxygen species in ischemia/reperfusion. Int J Mol Sci 2020;21:9382.
Shibata A, Hanatani A, Izumi Y, Kitada R, Iwata S, Yoshiyama M. Serum brain‐derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure. Heart Vessels 2018;33:1325–1333.
Bhullar AS, Anoveros‐Barrera A, Dunichand‐Hoedl A, Martins K, Bigam D, Khadaroo RG, et al. Lipid is heterogeneously distributed in muscle and associates with low radiodensity in cancer patients. J Cachexia Sarcopenia Muscle 2020;11:735–747.
Meyer HJ, Kardas H, Schramm D, Bär C, Wienke A, Borggrefe J, et al. CT‐defined pectoralis muscle mass and muscle density are associated with mortality in acute pulmonary embolism. A multicenter analysis. Clin Nutr 2023;42:1036–1040.